CYTL1 inhibits tumor metastasis with decreasing STAT3 phosphorylation

CYTL1 is a novel cytokine that was first identified in CD34(+) hematopoietic cells. We previously prepared recombinant CYTL1 and verified that it chemoattracted human monocytes via the CCR2/ERK pathway. It has been reported that CYTL1 plays contradictory roles in neuroblastoma and lung cancer. We fo...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncoimmunology
Asıl Yazarlar: Wang, Xiaolin, Li, Ting, Cheng, Yingying, Wang, Pingzhang, Yuan, Wanqiong, Liu, Qiyao, Yang, Fan, Liu, Qiang, Ma, Dalong, Ding, Shigang, Wang, Jun, Han, Wenling
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Taylor & Francis 2019
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6492975/
https://ncbi.nlm.nih.gov/pubmed/31069137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2019.1577126
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller